Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases
Tetsuro Matsuhashi(Tohoku University), Takaaki Abe(Tohoku University)
Cited by 68
Related Papers
Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5
|PLoS ONE|2020|36
A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β1 pathways
|Scientific Reports|2017|30
Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5
|bioRxiv (Cold Spring Harbor Laboratory)|2020|11